{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:10:17Z","timestamp":1678558217989},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1985,6]]},"DOI":"10.1007\/bf00174168","type":"journal-article","created":{"date-parts":[[2004,8,15]],"date-time":"2004-08-15T13:54:35Z","timestamp":1092578075000},"page":"187-189","source":"Crossref","is-referenced-by-count":10,"title":["Phase II studies of mitoxantrone in patients with primary liver cancer"],"prefix":"10.1007","volume":"3","author":[{"given":"Geoffrey","family":"Falkson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barend Johannes","family":"Coetzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00174168_CR1","first-page":"1516","volume":"40","author":"DD Von Hoff","year":"1980","unstructured":"Von Hoff DD, Pollard E, Kuhn J, Murray E, Coltman CA Jr: Phase I clinical investigation of DHAD (NSC 301739), a new anthracenedione. Cancer Res 40:1516\u20131518, 1980","journal-title":"Cancer Res"},{"key":"BF00174168_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00255455","volume":"4","author":"G Falkson","year":"1980","unstructured":"Falkson G, Von Hoff D, Klaassen D, du Plessis H, van der Merwe CF, van der Merwe AM, Carbone PP: A phase II study of neocarzinostatin (NSC 157365), in malignant hepatoma. Cancer Chemother Pharmacol 4:33\u201336, 1980","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"BF00174168_CR3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.1984.2.6.581","volume":"2","author":"G Falkson","year":"1984","unstructured":"Falkson G, MacIntyre JM, Schutt AJ, Coetzer BJ, Johnson LA, Simson IW, Douglas HO Jr: Neocarzinostatin versus m-AMSA or doxorubicin in hepatocellular carcinoma. J Clin Oncol 2(6):581\u2013584, 1984","journal-title":"J Clin Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00174168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00174168\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00174168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00174168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:53:21Z","timestamp":1678557201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00174168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,6]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,6]]}},"alternative-id":["BF00174168"],"URL":"https:\/\/doi.org\/10.1007\/bf00174168","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,6]]}}}